Market Cap (In USD)
40.53 Million
Revenue (In USD)
16.03 Million
Net Income (In USD)
-18.83 Million
Avg. Volume
152.66 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 5.25-17.8425
- PE
- -3.54
- EPS
- -1.59
- Beta Value
- 0.562
- ISIN
- US28531P2020
- CUSIP
- 28531P103
- CIK
- 1560258
- Shares
- 7193090.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Daniel S. Goldberger
- Employee Count
- -
- Website
- https://www.electrocore.com
- Ipo Date
- 2018-06-22
- Details
- electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
More Stocks
-
6870
-
CON
-
6908Acer Gaming Inc.
6908
-
GGDVY
-
9412
-
1164
-
ECNLAquafil S.p.A.
ECNL
-
ENBEnbridge Inc.
ENB